Virtu Financial’s BriaCell Therapeutics Corp Warrant BCTXW Stock Holding History

Virtu Financial’s Portfolio BCTXW Stock Details BCTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-26,293	Closed	-$1K	–	1644
2025 Q4	$1K	Buy	+26,293	New	+$1.31K	﹤0.01%	1569
2021 Q3	–	Sell	-10,445	Closed	-$19K	–	1510
2021 Q2	$19K	Buy	+10,445	New	+$13K	﹤0.01%	1411

Virtu Financial's BCTXW Position: Q1 2026 in Review

Virtu Financial sold out of BriaCell Therapeutics Corp Warrant (BCTXW) in Q1 2026, closing a stake of 26,293 shares — an estimated $1K sold.

Virtu Financial first reported a position in BCTXW in Q2 2021 and held it in 2 quarters. The position peaked at $19K in Q2 2021. 0 funds tracked by Wall St. Rank hold BCTXW as of Q1 2026.

Virtu Financial reported no remaining BriaCell Therapeutics Corp Warrant position as of Q1 2026 after selling out during the quarter.
Virtu Financial sold 26,293 BriaCell Therapeutics Corp Warrant shares in Q1 2026, an estimated $1K.
Virtu Financial first reported a position in BriaCell Therapeutics Corp Warrant in Q2 2021 and held it in 2 quarters.
Virtu Financial's BriaCell Therapeutics Corp Warrant position peaked at $19K in Q2 2021.
0 funds tracked by Wall St. Rank held BriaCell Therapeutics Corp Warrant as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.